U.S. flag

An official website of the United States government

NM_000112.4(SLC26A2):c.2032_2033delinsCT (p.Gly678Leu) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Dec 1, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001806725.1

Allele description [Variation Report for NM_000112.4(SLC26A2):c.2032_2033delinsCT (p.Gly678Leu)]

NM_000112.4(SLC26A2):c.2032_2033delinsCT (p.Gly678Leu)

Gene:
SLC26A2:solute carrier family 26 member 2 [Gene - OMIM - HGNC]
Variant type:
Indel
Cytogenetic location:
5q32
Genomic location:
Preferred name:
NM_000112.4(SLC26A2):c.2032_2033delinsCT (p.Gly678Leu)
HGVS:
  • NC_000005.10:g.149981625_149981626delinsCT
  • NG_007147.2:g.22743_22744delinsCT
  • NM_000112.4:c.2032_2033delinsCTMANE SELECT
  • NP_000103.2:p.Gly678Leu
  • LRG_684t1:c.2032_2033delinsCT
  • LRG_684:g.22743_22744delinsCT
  • NC_000005.9:g.149361188_149361189delinsCT
  • NM_000112.3:c.2032_2033delinsCT
Protein change:
G678L
Links:
dbSNP: rs2113699627
NCBI 1000 Genomes Browser:
rs2113699627
Molecular consequence:
  • NM_000112.4:c.2032_2033delinsCT - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002050897Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Dec 1, 2021)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV002050897.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Variant summary: SLC26A2 c.2032_2033delinsCT (p.Gly678Leu) results in a non-conservative amino acid change located in the STAS domain (IPR002645) of the encoded protein sequence. Two of three in-silico tools predict a damaging effect of the variant on protein function. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 7.1e-06 in 282510 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.2032_2033delinsCT in individuals affected with Sulfate Transporter-Related Osteochondrodysplasia and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024